Navigation Links
Continuous Blood Pressure Monitoring Predicts Risks
Date:11/24/2008

'Ambulatory' measures are better than readings in doctor's office, study says

MONDAY, Nov. 24 (HealthDay News) -- Round-the-clock blood pressure measurements, especially those during the night, are better predictors of major cardiovascular problems than readings taken in a doctor's office for people whose high blood pressure is hardest to treat, a Brazilian study shows.

"Ambulatory blood pressure monitoring should be performed during the whole 24 hours, with separate analyses of the daytime and nighttime periods, because it seems that nighttime blood pressures are better cardiovascular risk factors than are daytime blood pressure," said the report in the Nov. 24 issue of Archives of Internal Medicine by physicians at the Federal University of Rio de Janeiro.

The researchers followed 556 people with what doctors call "resistant hypertension" -- blood pressure that remains dangerously high despite standard drug therapy. More than 10 percent of people with high blood pressure are in that category, the report said.

Some of the participants in the Brazilian study underwent usual regular blood pressure measurements in a doctor's office, while others had continuous monitoring at home (ambulatory monitoring) -- every 15 minutes during the day and every 30 minutes at night.

The clear and present danger of high blood pressure was evidenced by the high incidence of strokes, heart attacks, heart failure and deaths, which occurred in 19.6 percent of the study group, with an average follow-up period of 4.8 years. Office blood pressure measurements did not predict any of these events, whereas higher round-the-clock readings did, the report said.

The report is yet another instance of a common heart test failing to predict trouble ahead. A study reported earlier this month by physicians at the London Chest Hospital in England found that performing an electrocardiogram, the standard test for measuring the activity of the heart, is of little use in forecasting future coronary problems for people with chest pain.

On the hypertension front, previous studies have indicated that "ambulatory blood pressure measurements do predict things better, in part because they are so frequent," said Dr. William C. Cushman, professor of preventive medicine and medicine at the University of Tennessee.

"There is a growing body of evidence that ambulatory blood pressure measurements may be more accurate than taking office blood pressures," Cushman said.

And yet, he added, "there clearly have been dramatic benefits from treatment based on office blood pressures."

An unanswered question is whether treatment based on nighttime blood pressure measurements can reduce the risks of hypertension, Cushman said. "The real problem is that virtually all the studies showing that treatment is effective have been based on office readings," he said.

That echoed the findings of the Brazilian researchers, who wrote that their study "raises the question of whether therapeutic interventions directed specifically at controlling nighttime hypertension will be able to improve cardiovascular prognosis compared with the traditional approach of controlling daytime blood pressure levels. This important clinical question should be addressed in future prospective interventional studies."

What is needed is a study in which people with resistant high blood pressure would be randomly selected to receive treatment based either on office readings or round-the-clock measurements, Cushman said. "We don't have treatment studies that have used that approach," he said.

Resistant hypertension can be treated successfully with combinations of drugs such as diuretics, ACE inhibitors and calcium channel blockers, he said.

Not all doctors are convinced that round-the-clock monitoring is the total solution.

It's clearly of value in treating people with resistant hypertension, but often is "not practical in terms of convenience to the patient," said Dr. David A. Calhoun, professor of medicine at the University of Alabama at Birmingham.

"We tell all our patients to invest in a home monitor," Calhoun said. "Once we have done that and have confidence in their measurements, we have them keep a blood pressure diary and bring it in each week as a guide to decision-making."

Dr. John Bisognano, associate professor of medicine and cardiology at the University of Rochester, in New York, said continuous monitoring doesn't solve the basic problem with resistant hypertension, which is that "these are people who need better blood pressure control."

"It's like putting a better thermometer in a burning building," he said. "It doesn't really matter whether you get more accurate temperatures or not."

Continuous monitoring is of more value for people with borderline hypertension, Bisognano said. "It can tell you whether to initiate treatment and how intensely you need to treat them," he said.

More information

The American Heart Association has guidelines for the diagnosis and treatment of resistant hypertension.



SOURCES: William C. Cushman, M.D., professor of preventive medicine and medicine, University of Tennessee, Memphis; David A. Calhoun, M.D., professor of medicine, University of Alabama at Birmingham; John Bisognano, M.D., Ph.D., associate professor of medicine and cardiology, University of Rochester, N.Y.; Nov. 24, 2008, Arcives of Internal Medicine


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. GEMS Introduces Ultrasonic Continuous Liquid Level Sensor with Multipoint Switch Capability
2. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
3. Automated, Wearable Kidney Offers Continuous Dialysis
4. New nanotube sensor can continuously monitor minute amounts of insulin
5. ThalesNano Announces the Launch of X-Cube Flash(TM), its Next Generation High Temperature and Pressure Continuous Process Reactor
6. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
7. Echo Therapeutics Announces Positive Results from Symphony(TM) Transdermal Continuous Glucose Monitoring System Study at Tufts Medical Center
8. Continuous Doctor Care Key to Childhood Screenings
9. In Early Childhood, Continuous Care by One Doctor Improves Delivery of Health Screenings
10. In early childhood, continuous care by 1 doctor improves delivery of health screenings
11. Gulf Coast Hospital Chooses Global Med Technologies(R) Blood System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... ... significantly higher rates of several common cancer screenings, especially among women. Cancer screenings ... and survival rates. , The study,“What Does Medicaid Expansion Mean for Cancer ...
(Date:2/10/2016)... ... February 10, 2016 , ... The ... World Molecular Imaging Congress (WMIC), will be held in New York City, NY ... “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging reveals a ...
(Date:2/10/2016)... ... ... LaserShip, a regional parcel carrier that services the eastern U.S., donated and ... in order to aid in the Flint water crisis. In 2014, LaserShip acquired Prestige ... Clio, only 15 miles away from Flint. , “We have deep roots in the ...
(Date:2/10/2016)... Beach, Florida (PRWEB) , ... February 10, 2016 ... ... innovative weather-forecasting company is unveiling its revolutionary new 2.0 version at the International ... MetLoop has “put the power of the world's most advanced weather technology in ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intermedix announced ... Emergency Medicine , an emergency medicine professional association, to support the organization's newly ... The American Academy of Emergency Medicine, or AAEM, seeks to empower emergency physicians ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Fla. , Feb. 11, 2016 PLAD, ... started out 2016 with sales exceeding company targets, are ... have received their trademark from the United States Patent ... Bobby Clark , Chief Executive Officer of PLAD, Inc.  ... of Pennsylvania with two new ...
(Date:2/11/2016)... , Feb. 11, 2016  Delcath Systems, ... and medical device company focused on oncology with ... metastatic liver cancers, announces the engagement of ... Company,s Global Medical Consultant. Dr. Birgerson will provide ... Company,s clinical operations team to help ensure timely ...
(Date:2/11/2016)... 11, 2016  Aytu BioScience, Inc. (OTCQX: AYTU), a ... and related conditions, announced today that the Company will ... of 2016 on Tuesday, February 16, 2016, at 4:30 ... provide an overview of its business and growth strategy, ... ended December 31, 2015. --> ...
Breaking Medicine Technology: